AT116543T - Osmotic dosage for the administration of liquid medicines. - Google Patents

Osmotic dosage for the administration of liquid medicines.


Publication number
AT116543T AT91908069T AT91908069T AT116543T AT 116543 T AT116543 T AT 116543T AT 91908069 T AT91908069 T AT 91908069T AT 91908069 T AT91908069 T AT 91908069T AT 116543 T AT116543 T AT 116543T
Prior art keywords
osmotic dosage
liquid medicines
Prior art date
Application number
Other languages
German (de)
Patrick S-L Wong
Felix Theeuwes
Brian L Barclay
Michael Howard Dealey
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/502,705 priority Critical patent/US5324280A/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of AT116543T publication Critical patent/AT116543T/en



    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
AT91908069T 1990-04-02 1991-03-28 Osmotic dosage for the administration of liquid medicines. AT116543T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/502,705 US5324280A (en) 1990-04-02 1990-04-02 Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

Publications (1)

Publication Number Publication Date
AT116543T true AT116543T (en) 1995-01-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908069T AT116543T (en) 1990-04-02 1991-03-28 Osmotic dosage for the administration of liquid medicines.

Country Status (17)

Country Link
US (2) US5324280A (en)
EP (1) EP0523172B1 (en)
JP (1) JP2927956B2 (en)
KR (1) KR0176724B1 (en)
AT (1) AT116543T (en)
AU (1) AU645315B2 (en)
CA (1) CA2039456C (en)
DE (2) DE69106501T2 (en)
DK (1) DK0523172T3 (en)
ES (1) ES2075444T3 (en)
FI (1) FI924419A0 (en)
IE (1) IE62394B1 (en)
NO (1) NO923756L (en)
NZ (1) NZ237642A (en)
PT (1) PT97203B (en)
WO (1) WO1991015196A1 (en)
ZA (1) ZA9102380B (en)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693907B1 (en) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa The method of administration of granulocyte colony stimulating factor solutions.
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO1995010989A1 (en) * 1993-10-19 1995-04-27 Scimed Life Systems, Inc. Intravascular stent pump
US5496360A (en) * 1994-04-12 1996-03-05 Ventritex, Inc. Implantable cardiac electrode with rate controlled drug delivery
DK0768867T3 (en) * 1994-06-13 2002-10-28 Alza Corp A dosage form for administering the drug in the liquid formulation
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
US5531682A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for adding marker dye to nutritional product during enternal tube feeding
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US6036669A (en) 1995-01-13 2000-03-14 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
FR2731154B1 (en) * 1995-03-03 1997-05-09 Roussel Uclaf pharmaceutical compositions comprising derivatives of dinoreburnamenine
US5651979A (en) * 1995-03-30 1997-07-29 Gel Sciences, Inc. Apparatus and method for delivering a biologically active compound into a biological environment
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
US6156331A (en) * 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
DE69734168D1 (en) * 1996-02-02 2005-10-13 Alza Corp Implantable system sustained release
US6261584B1 (en) 1996-02-02 2001-07-17 Alza Corporation Sustained delivery of an active agent using an implantable system
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
KR100576583B1 (en) * 1997-12-22 2006-05-04 알자 코포레이션 Rate controlling membranes for controlled drug delivery devices
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
ES2187156T3 (en) * 1998-05-14 2003-05-16 Alza Corp Antidepressant therapy.
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
CA2341297C (en) * 1998-09-09 2009-02-24 Alza Corporation Dosage form comprising liquid formulation
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US6706282B1 (en) * 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
GB9824658D0 (en) * 1998-11-11 1999-01-06 Brown Malcolm D A capsule based drug delivery system
ES2213404T3 (en) * 1998-12-17 2004-08-16 Alza Corporation Processing filled gelatin capsules of liquid in controlled release systems through multiple coatings.
IL143778D0 (en) 1998-12-18 2002-04-21 Alza Corp Transparent transdermal nicotine delivery devices
US6198966B1 (en) 1999-02-26 2001-03-06 Medtronic, Inc. Recirculating implantable drug delivery system
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
JP3061616B1 (en) * 1999-04-09 2000-07-10 株式会社セラリカ野田 Low-calorie - preparation Russia - Yaruzeri -
DE19923817A1 (en) * 1999-05-18 2000-11-23 Roland Bodmeier Capsule with controlled active ingredient release comprises active ingredient-containing filling, capsule shell, swelling agent and water-insoluble layer
US20020161387A1 (en) * 2000-06-22 2002-10-31 Blanco Ernesto E. Safety trocar with progressive cutting tip guards and gas jet tissue deflector
US20040230155A1 (en) * 1999-06-22 2004-11-18 Erblan Surgical Inc. Insufflator and method of use
US20040230160A1 (en) * 2000-06-22 2004-11-18 Erblan Surgical Inc. Safety trocar including sealing member
US20060015075A1 (en) * 1999-06-22 2006-01-19 Erblan Surgical Inc. Guarded infusor needle and infusor locking system
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
KR100738276B1 (en) 1999-12-09 2007-07-12 알자 코포레이션 Antiviral medication
JP2003516345A (en) * 1999-12-09 2003-05-13 アルザ・コーポレーション Antiviral drugs
AR026148A1 (en) * 2000-01-21 2003-01-29 Osmotica Argentina S A Osmotic device preformed passageway that increases in size
WO2001056543A1 (en) 2000-02-04 2001-08-09 Alza Corporation Osmotically-driven fluid dispenser and coating composition
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
GB2398499B (en) * 2000-02-16 2004-11-24 Bioprogress Technology Ltd Two layer capsules
GB0003424D0 (en) * 2000-02-16 2000-04-05 Bioprogress Tech Int Inc A controlled release capsule
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
WO2002054996A2 (en) * 2000-10-23 2002-07-18 Mark Alfonso Terazosin transdermal device and methods
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
IL155730D0 (en) * 2000-11-03 2003-11-23 Biomedicines Inc Method for short-term and long-term drug dosimetry
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
DE10100689A1 (en) * 2001-01-09 2002-07-18 Henkel Kgaa Washing and cleaning-active microcapsules containing substances
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
EP2316394B1 (en) 2001-06-12 2016-11-23 The Johns Hopkins University Reservoir device for intraocular drug delivery
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
WO2003005877A2 (en) * 2001-07-12 2003-01-23 Given Imaging Ltd. Device and method for examining a body lumen
US7349733B2 (en) * 2001-11-02 2008-03-25 Ceramatel, Inc. Iontophoretic drug delivery systems
AU2002365436B8 (en) * 2001-11-09 2008-04-03 Intarcia Therapeutics, Inc. Method for treating diseases with omega interferon
HU0402451A3 (en) * 2001-12-19 2008-04-28 Alza Corp Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
CN1620281A (en) * 2001-12-19 2005-05-25 阿尔扎公司 Formulation & dosage form for the controlled delivery of therapeutic agents
US6775570B2 (en) 2002-02-04 2004-08-10 Ceramatec, Inc. Iontophoretic treatment device
US7047069B2 (en) 2002-02-04 2006-05-16 Ceramatec, Inc. Iontophoretic fluid delivery device
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
MY135711A (en) * 2002-06-17 2008-06-30 Alza Corp Osmotic delivery system with early zero order push power engine
AR039744A1 (en) * 2002-06-26 2005-03-09 Alza Corp Methods and dosage forms to increase solubility of drug compositions for controlled administration
BR0312429A (en) * 2002-06-26 2005-04-19 Alza Corp Piston deformity and minimally efficient volume for distribution of drugs osmosis systems
TW200414900A (en) * 2002-06-28 2004-08-16
US20040115262A1 (en) * 2002-07-29 2004-06-17 Frank Jao Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2003291667A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
TW200418527A (en) * 2002-10-31 2004-10-01 Alza Corp Dosage form providing ascending release of liquid formulation
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
US7491234B2 (en) * 2002-12-03 2009-02-17 Boston Scientific Scimed, Inc. Medical devices for delivery of therapeutic agents
MXPA05005812A (en) * 2002-12-11 2005-08-16 Pfizer Prod Inc Controlled-release of an active substance into a high fat environment.
SI1635787T1 (en) 2003-06-26 2012-04-30 Psivida Inc Bioerodible sustained release drug delivery systems
CN1863557B (en) * 2003-06-26 2010-06-16 普西维达公司 In-situ gelling drug delivery system
JP5628467B2 (en) * 2003-06-26 2014-11-19 シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. Biodegradable sustained release drug delivery system
MXPA06001548A (en) * 2003-08-06 2006-09-04 Johnson & Johnson Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation.
CA2536507A1 (en) * 2003-08-22 2005-03-10 Alza Corporation Stepwise delivery of topiramate over prolonged period of time
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
EP1684713A1 (en) * 2003-11-14 2006-08-02 ALZA Corporation Controlled release of topirimate in liquid dosage forms
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
AU2004308973A1 (en) * 2003-12-23 2005-07-14 Alza Corporation Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
AU2004312082A1 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc. Novel drug compositions and dosage forms
JP2007517063A (en) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン Novel pharmaceutical compositions of topiramate and dosage forms
NZ582466A (en) * 2004-07-30 2011-09-30 Adeza Biomedical Corp Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
US20060045891A1 (en) * 2004-08-24 2006-03-02 Lovalenti Phillip M Density-matched suspension vehicles and pharmaceutical suspensions
DE602006003639D1 (en) * 2005-01-27 2008-12-24 Alza Corp Oral osmotic dosage form in with membrane with high flux density
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US8052996B2 (en) 2005-02-03 2011-11-08 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
JP2008536928A (en) * 2005-04-19 2008-09-11 アルザ・コーポレーシヨン Tramadol and substances that comprise gabapentin, the combination of
MX2007015171A (en) * 2005-06-02 2008-04-22 Thallion Pharmaceuticals Inc Formulation comprising farnesyl dibenzodiazepinone and a pharmaceutically acceptable surfactant.
AU2006269944A1 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
AR055099A1 (en) * 2005-07-28 2007-08-08 Alza Corp Liquid formulations for controlled administration of benzisoxazole derivatives
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
DK2049081T3 (en) * 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotic delivery systems and piston arrangements
US20080177219A1 (en) * 2007-01-23 2008-07-24 Joshi Ashok V Method for Iontophoretic Fluid Delivery
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
GB0707127D0 (en) * 2007-04-13 2007-05-23 Zysis Ltd Pharmaceutical compositions
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20090087484A1 (en) * 2007-09-28 2009-04-02 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US20090110724A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of pain
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
DK2240155T3 (en) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Devices, formulations and methods for delivery of multiple beneficial agents
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
US20090312627A1 (en) * 2008-06-16 2009-12-17 Matott Laura A Radio-labeled ingestible capsule
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
JP5577354B2 (en) 2009-01-29 2014-08-20 フォーサイト・ビジョン フォー・インコーポレーテッド Treatment device
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
AU2010234343A1 (en) * 2009-04-09 2011-11-24 Alkermes Pharma Ireland Limited Controlled-release clozapine compositions
CN105726201A (en) * 2009-05-18 2016-07-06 多斯医学公司 Drug eluting ocular implant
KR20120029428A (en) 2009-06-16 2012-03-26 브리스톨-마이어스 스큅 컴퍼니 Dosage forms of apixaban
WO2011006066A1 (en) 2009-07-10 2011-01-13 Ironwood Pharmaceuticals, Inc. Cb receptor agonists
JP5600174B2 (en) * 2009-09-15 2014-10-01 チーム アカデミー オブ ファーマシューティカル サイエンス Osmotic pump type controlled release tablet and method for producing the same
US8298561B2 (en) 2009-09-28 2012-10-30 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US8674115B2 (en) 2009-12-23 2014-03-18 Ironwood Pharmaceuticals, Inc. CRTH2 modulators
CN102740830A (en) * 2009-12-23 2012-10-17 普西维达公司 Sustained release delivery devices
EP2515759A4 (en) 2009-12-23 2015-01-21 Given Imaging Inc Method of evaluating constipation using an ingestible capsule
US20130178453A1 (en) 2010-02-09 2013-07-11 Ironwood Pharmaceuticals, Inc. Cannabinoid Agonists
US20130196960A1 (en) 2010-02-09 2013-08-01 Ironwood Pharmaceuticals, Inc. Cannabinoid Receptor Agonists
WO2011115804A1 (en) 2010-03-17 2011-09-22 Ironwood Pharmaceuticals, Inc. Sgc stimulators
JP5860459B2 (en) 2010-06-30 2016-02-16 アイアンウッド ファーマシューティカルズ インコーポレイテッド sGC stimulant
US20130216552A1 (en) 2010-07-12 2013-08-22 Ironwood Pharmaceuticals, Inc. Crth2 modulators
WO2012009134A1 (en) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Crth2 modulators
CA2807535C (en) 2010-08-05 2019-03-19 Forsight Vision4, Inc. Injector apparatus and method for drug delivery
CN103209664A (en) 2010-08-05 2013-07-17 弗赛特影像4股份有限公司 Implantable therapeutic device
US9498239B2 (en) 2010-08-30 2016-11-22 SinuSys Corporation Devices and methods for inserting a sinus dilator
RU2016101964A3 (en) 2010-11-09 2018-11-21
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP2726016A4 (en) 2011-06-28 2015-07-29 Forsight Vision4 Inc Diagnostic methods and apparatus
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
EP2755600A4 (en) 2011-09-16 2015-09-16 Forsight Vision4 Inc Fluid exchange apparatus and methods
CA2861804A1 (en) 2011-12-27 2013-07-04 Ironwood Pharmaceuticals, Inc. 2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
CA2862297A1 (en) 2012-02-29 2013-09-06 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US20150080381A1 (en) 2012-04-12 2015-03-19 Ironwood Pharmaceuticals, Inc. Methods of treating alopecia and acne
US9309235B2 (en) 2012-09-18 2016-04-12 Ironwood Pharmaceuticals, Inc. SGC stimulators
WO2014047325A1 (en) 2012-09-19 2014-03-27 Ironwood Pharmaceuticals, Inc. Sgc stimulators
US9968603B2 (en) 2013-03-14 2018-05-15 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
BR112015023349A2 (en) 2013-03-15 2017-07-18 Ironwood Pharmaceuticals Inc compound, pharmaceutical composition, and method of treating a disease, health condition or disorder
EP2978393A1 (en) 2013-03-28 2016-02-03 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
EP3035991A1 (en) * 2013-08-19 2016-06-29 TARIS Biomedical LLC Multi-unit drug delivery devices and methods
US20160310408A1 (en) * 2013-12-06 2016-10-27 Durect Corporation Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
WO2015089182A1 (en) 2013-12-11 2015-06-18 Ironwood Pharmaceuticals, Inc. Sgc stimulators
MX2017000609A (en) 2014-07-15 2017-04-27 Forsight Vision4 Inc Ocular implant delivery device and method.
EP3177289A4 (en) 2014-08-08 2018-03-21 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US20170291889A1 (en) 2014-09-17 2017-10-12 Ironwood Pharmaceuticals, Inc. Pyrazole derivatives as sgc stimulators
WO2016044445A2 (en) 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
CN107406421A (en) 2014-09-17 2017-11-28 铁木医药有限公司 Sgc stimulators
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
BR112019004468A2 (en) 2016-09-02 2019-05-28 Ironwood Pharmaceuticals Inc sgc stimulants
CA3042713A1 (en) 2016-11-08 2018-05-17 Cyclerion Therapeutics, Inc. Sgc stimulators
CN110267658A (en) 2016-11-08 2019-09-20 塞科里昂医疗股份有限公司 CNS disease is treated with sGC stimulant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
US4203442A (en) * 1977-08-29 1980-05-20 Alza Corporation Device for delivering drug to a fluid environment
US4180073A (en) * 1977-08-29 1979-12-25 Alza Corporation Device for delivering drug to biological environment
US4203440A (en) * 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
US4203441A (en) * 1978-12-18 1980-05-20 Alza Corporation Osmotically triggered device with gas generating means
FR2524311A1 (en) * 1982-04-05 1983-10-07 Azalbert Gilles Multi:effect medical capsule with compartments contg. different medica - which are ingested simultaneously for programmed release to treat patient
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4781714A (en) * 1983-11-02 1988-11-01 Alza Corporation Dispenser for delivering thermo-responsive composition
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4929233A (en) * 1988-08-26 1990-05-29 Alza Corporation Implantable fluid imbibing pump with improved closure

Also Published As

Publication number Publication date
EP0523172B1 (en) 1995-01-04
EP0523172A1 (en) 1993-01-20
US5413572A (en) 1995-05-09
WO1991015196A1 (en) 1991-10-17
NO923756D0 (en) 1992-09-28
JP2927956B2 (en) 1999-07-28
DE69106501D1 (en) 1995-02-16
AU7673791A (en) 1991-10-30
DE69106501T2 (en) 1995-05-11
JPH07502252A (en) 1995-03-09
ZA9102380B (en) 1992-01-29
ES2075444T3 (en) 1995-10-01
IE62394B1 (en) 1995-01-25
IE911040A1 (en) 1991-10-09
PT97203B (en) 1999-03-31
NZ237642A (en) 1993-07-27
PT97203A (en) 1991-12-31
FI924419D0 (en)
CA2039456C (en) 2003-11-11
CA2039456A1 (en) 1991-10-03
NO923756L (en) 1992-12-02
US5324280A (en) 1994-06-28
FI924419A0 (en) 1992-10-01
KR0176724B1 (en) 1999-03-20
AU645315B2 (en) 1994-01-13
FI924419A (en) 1992-10-01
DK0523172T3 (en) 1995-07-10

Similar Documents

Publication Publication Date Title
DE69133123T2 (en) The transdermal delivery of drugs nearly saturated with an increased flow of medication
DE69113847T2 (en) Syringe with the displayed dose.
DE69332222T2 (en) Enythropoietin containing drug delivery system
DE69105202T2 (en) System for the administration of medicaments by a two-stage iontophoresenverfahren.
DE69110253T2 (en) Liquid dispenser.
DE3784594T2 (en) Microcapsules containing pharmaceutical compositions.
AT46836T (en) Ultrasonic liquid atomizer.
NO905125L (en) Administration device.
IT1155619B (en) Bandage for the administration of medication
ES2012391B3 (en) Liquid dispenser.
NO880124L (en) Therapeutic system tungtopploeselige active substances.
DE69203990D1 (en) Device for transdermal administration of drugs.
NO872989D0 (en) Based medicine for controlled frigjoerelse.
DE68902328T2 (en) Liquid kupplungszusammenbauten.
DE69330547T2 (en) Preparation with drug delivery verzörgerter
DE3485581D1 (en) Antioestrogenes drug for percutaneous administration.
DE59102210D1 (en) Galanthemin containing pharmaceutical formulation for the treatment of alcoholism.
DE3869142D1 (en) System for infusion of drugs.
DK163711C (en) Analgesic preparation on the unit dosage form
FI913410A (en) The compositions of pharmaceutical frigoerande continuously.
NO882565L (en) Generic zero-order drug delivery system.
DE69018647D1 (en) Drug.
DE69112895D1 (en) Pharmaceutical compounds.
DE68909822T2 (en) Liquid container.
NO873766L (en) Emanasjonsinnretning for volatile liquids.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee